Clinical trial participants help move research forward while gaining access to the latest potential treatments. Clinical trials are available for patients who have been diagnosed with Parkinson's within the last three years and have not started medication yet.
For example, patients must not be taking.
- Mirapex® (pramipexole)
- Azilect® (rasagiline)
- Stalevo (carbidopa, levodopa and entacapone)
- Sinemet (carbidopa and levodopa)
- Symmetrel® (amantadine)
- Requip® (ropinirole)
- Eldepryl® (selegiline)
- Cogentin® (benztropine)
